Woodline Partners LP

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1784547 San Francisco, CA

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48,793,419

+$12,417,708 QoQ

Shares Held

500,548

+15.5% QoQ

Ownership

0.895%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#28

of 269 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. DNTH ranks #28 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,793,419	500,548	+15.5%	Shares	Sole	2026-08-14
2026-03-31	$36,375,711	433,457	+103.4%	Shares	Sole	2026-05-15
2025-12-31	$8,781,315	213,087	+399.1%	Shares	Sole	2026-02-17
2025-09-30	$1,680,166	42,698	-89.3%	Shares	Sole	2025-11-14
2025-06-30	$7,461,389	400,504	+33.3%	Shares	Sole	2025-08-14
2025-03-31	$5,451,142	300,504	0.0%	Shares	Sole	2025-05-15
2024-12-31	$6,550,987	300,504	+20.0%	Shares	Sole	2025-02-14
2024-09-30	$6,858,799	250,504	+0.1%	Shares	Sole	2024-11-14
2024-06-30	$6,478,618	250,333	—	Shares	Sole	2024-08-14
2022-09-30 MGTA	—	1,304,946	+39.8%	Shares	Sole	2022-11-14
2022-06-30 MGTA	—	933,181	+17.2%	Shares	Sole	2022-08-15
2022-03-31 MGTA	—	796,461	+201.1%	Shares	Sole	2022-05-16
2021-12-31 MGTA	—	264,477	-48.7%	Shares	Sole	2022-02-14
2021-09-30 MGTA	—	515,670	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.